* Guardion Health Sciences Inc GHSI.OQ reported a
quarterly
adjusted loss of 3 cents per share for the quarter ended in
September. The lone analyst forecast for the quarter was for a
loss of 2 cents per share.
* Revenue was $2.66 million; analysts expected $3.55
million.
* Guardion Health Sciences Inc's reported EPS for the
quarter was
a loss of 3 cents.
* The mean earnings estimate of analysts had risen by
about 55.6%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Guardion Health Sciences Inc shares had risen by 6.1% this
quarter and lost 77.4% so far this year.
* The company reported a quarterly loss of $1.7 million.
* Wall Street's median 12-month price target for Guardion
Health
Sciences Inc is $0.70
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
18 at 02:37 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.02 -0.03 Missed
Jun. 30 2022 -0.04 -0.03 Beat
Mar. 31 2022 -0.08 -0.07 Beat